COMP <GO>
ASMB vs MRK // GROSS PROFIT MARGIN
Assembly Biosciences Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ASMB 1
— MRK 9
■ METRIC PARITY
LAST: $20.13 (-3.50%) • MKT CAP: $424.7M
gross-margins
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
gross-margins
74.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASMB VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASMB | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.50% | 20.70% | -27.20 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.69% | 3.42% | -13.11 | MRK | /fcf-yield <GO> |
| Operating Margin | -16.80% | 34.30% | -51.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | -8.50% | 28.10% | -36.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 153.50% | 1.30% | +152.20 | ASMB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.57 | 5.19 | -3.62 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 51.7 | -9.90 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $424.7M | $361.02B | -$360.60B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASMB REV | MRK REV | ASMB GROSS % | MRK GROSS % | ASMB FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.3M | $65.01B | — | 74.8% | -$41.2M | $12.36B |
| FY 2024 | $28.5M | $64.17B | — | 76.3% | -$51.1M | $18.10B |
| FY 2023 | $0 | $60.12B | — | — | $22.7M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASMB // BETA —
MRK // BETA 0.92